After 24 weeks, mean weight loss with phentermine/topiramate ER in PCOS obese women was 8%, even higher than the 6.6% Weight loss reported at 56 weeks in the general population [171] However, cardiovascular safety concerns persist for this drug, particularly in people with PCOS, who are already at increased risk for cardiovascular complications compared to the general population [172]
We have seen time and again that celebrities influence peoples health and wellness choices, she told The Post
These changes are part of the bodys way of adapting to the pregnancy
Setting Realistic Expectations Understanding the typical semaglutide timeline helps prevent discouragement during the early weeks when dose adjustments may cause temporary side effects and weight loss is just beginning
Patients with a mean baseline HbA1c of 8.1% (range 6.5%-10.7%) were randomized to receive either SYMLIN or placebo, both administered before major meals as add-on to insulin therapy
Your clinician remains available for ongoing support, dose adjustments, and side-effect management